Refine
Year of publication
Document Type
- Preprint (668)
- Article (371)
- Part of a Book (2)
Has Fulltext
- yes (1041)
Is part of the Bibliography
- no (1041)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- iron (3)
- pp collisions (3)
- Beauty production (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Single electrons (2)
- lipocalin-2 (2)
- 900 GeV (1)
- ACL (1)
- ALICE detector (1)
- Adorno (1)
- Altertum (1)
- Anti-nuclei (1)
- Boosted Jets (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charisma (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Functional outcome (1)
- HBT (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Handlungstheorie (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hobbyarchäologie (1)
- ISR (1)
- Inclusive spectra (1)
- Innovation (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Kritische Theorie (1)
- Kupfer (1)
- Lazarsfeld (1)
- Material budget (1)
- Max Weber (1)
- Metallurgie (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Motor control (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Musiksoziologie (1)
- Neolithikum (1)
- Neural network (1)
- Nrf2 (1)
- Nuclear modification factor (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Poecilia mexicana (1)
- Post treatment (1)
- Princeton Radio Research Project (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- ROS (1)
- RTS (1)
- Rapidity Range (1)
- Re-injury (1)
- Recurrence (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Return to play (1)
- Return to sports (1)
- SLC7A11 (1)
- Secondary prevention (1)
- Sexual selection (1)
- Single muons (1)
- Systematic Uncertainty (1)
- TR (1)
- Technische Innovation (1)
- Therapy (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Vector Boson Production (1)
- Vor- und Frühgeschichte (1)
- Wissenschaftspraxis (1)
- Wissenssoziologie (1)
- Xenon-based gas mixture (1)
- Zivilisation (1)
- bortezomib (1)
- charisma (1)
- chelation therapy (1)
- citizen science (1)
- copper (1)
- critical theory (1)
- cross-linking (1)
- dE/dx (1)
- detector (1)
- erastin (1)
- experimental results (1)
- female choice (1)
- ferroportin (1)
- ferroptosis (1)
- heavy ion experiments (1)
- induction regimen (1)
- iron metabolism (1)
- iron-trafficking (1)
- kidney (1)
- lenalidomide (1)
- macrophage (1)
- macrophage polarization (1)
- metallurgy (1)
- multiple myeloma (1)
- neolithic (1)
- non-independent mate choice (1)
- p-eIF2α (1)
- polymeric micelle (1)
- polypept(o)ide (1)
- predator recognition (1)
- quark gluon plasma (1)
- renal cell carcinoma (1)
- renal failure (1)
- sociology of music (1)
- spectra (1)
- superparamagnetic iron oxide nanoparticles (1)
- theory of action (1)
- tumor microenvironment (1)
- tumor stroma (1)
- tumor-associated macrophages (TAM) (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1028)
- Frankfurt Institute for Advanced Studies (FIAS) (958)
- Informatik (924)
- Medizin (7)
- Gesellschaftswissenschaften (4)
- Informatik und Mathematik (3)
- Hochschulrechenzentrum (2)
- Institut für Ökologie, Evolution und Diversität (1)
- Kulturwissenschaften (1)
- Pharmazie (1)
Simple Summary: Renal insufficiency is frequently seen in newly diagnosed multiple myeloma and can be due to the disease itself but also caused by medical interventions or infections. Patients with severe renal insufficiency are known to have an adverse prognosis, but recently, it was shown that even moderately impaired kidney function can have long-term sequelae. Achieving quick disease control by effective antimyeloma therapy can lead to the recovery of renal function. We investigated the kidney-specific variables in a large cohort of 770 myeloma patients receiving three different three-drug regimens for initial myeloma treatment to learn more about the differential effects on kidney function in an early disease phase. All regimens had a positive impact on kidney function without a difference in the proportion of patients who reached normal renal function after three cycles. Interestingly, patients who received bortezomib, lenalidomide, and dexamethasone tended to have higher risk for a worse renal function following induction when compared to the initial values.
Abstract: Background: Preservation of kidney function in newly diagnosed (ND) multiple myeloma (MM) helps to prevent excess toxicity. Patients (pts) from two prospective trials were analyzed, provided postinduction (PInd) restaging was performed. Pts received three cycles with bortezomib (btz), cyclophosphamide, and dexamethasone (dex; VCD) or btz, lenalidomide (len), and dex (VRd) or len, adriamycin, and dex (RAD). The minimum required estimated glomerular filtration rate (eGFR) was >30 mL/min. We analyzed the percent change of the renal function using the International Myeloma Working Group (IMWG) criteria and Kidney Disease: Improving Global Outcomes (KDIGO)-defined categories. Results: Seven hundred and seventy-two patients were eligible. Three hundred and fifty-six received VCD, 214 VRd, and 202 RAD. VCD patients had the best baseline eGFR. The proportion of pts with eGFR <45 mL/min decreased from 7.3% at baseline to 1.9% PInd (p < 0.0001). Thirty-seven point one percent of VCD versus 49% of VRd patients had a decrease of GFR (p = 0.0872). IMWG-defined “renal complete response (CRrenal)” was achieved in 17/25 (68%) pts after VCD, 12/19 (63%) after RAD, and 14/27 (52%) after VRd (p = 0.4747). Conclusions: Analyzing a large and representative newly diagnosed myeloma (NDMM) group, we found no difference in CRrenal that occurred independently from the myeloma response across the three regimens. A trend towards deterioration of the renal function with VRd versus VCD may be explained by a better pretreatment “renal fitness” in the latter group.